BioCentury
ARTICLE | Finance

Investors are seeking only one thing: a sign the pandemic tide is shifting

In 2Q20, all eyes are on COVID-19 catalysts that could stabilize the market

April 4, 2020 2:41 AM UTC

The usual clinical and commercial catalysts are taking a back seat in the second quarter as buysiders are almost solely focused on COVID-19 milestones that will stabilize the market.

On the other hand, the virtual technologies taking root all over might help some companies soften the blow as they explore virtual launches while their sales forces are grounded. ...